Article
A Procoagulant Peptide Analog of the SARS-CoV-2 Nucleocapsid C-terminal Domain
2026-07-07
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Uncontrolled bleeding complicates trauma, surgery and many medical conditions. While currently available procoagulant therapies ( e . g ., plasma-derived factors, recombinant proteins, antifibrinolytics) have crucial limitations. <h4>Methods</h4> N389 (CQQTVTLLPAADLDDFSC) was synthesized by Fmoc solid-phase chemistry, characterized by HPLC and LC–MS, then tested in norma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7fef5d7a-b518-59bd-a651-8d7d8639a05d
- DOI
- 10.64898/2026.07.04.736500
